Literature DB >> 8958917

IL-12-deficient mice are defective but not devoid of type 1 cytokine responses.

J Magram1, J Sfarra, S Connaughton, D Faherty, R Warrier, D Carvajal, C Y Wu, C Stewart, U Sarmiento, M K Gately.   

Abstract

Interleukin-12 (IL-12) has been described as a pivotal molecule in the immune response based in part on its ability to influence the differentiation of T helper (Th) cells into a type 1 (Th1) phenotype. This event is crucial in that appropriate differentiation of naive T cells can determine susceptibility or resistance to given pathogens by influencing the balance between cellular and humoral immunity. In order to further delineate the role of IL-12 in the immune response, we generated mice deficient for this cytokine. IL-12 knockout mice were viable, fully fertile, and displayed no obvious developmental abnormalities. Upon immunological analysis, these mice demonstrated an impaired ability to effect a Th1 response as well as an impaired ability to produce interferon-gamma in response to endotoxin in vivo. These data establish an essential role for IL-12 in the generation of optimal Th1 responses in vivo, but weak responses can occur independently of IL-12.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8958917     DOI: 10.1111/j.1749-6632.1996.tb52655.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  30 in total

Review 1.  Molecular regulation of cytokine gene expression during the immune response.

Authors:  J P Viola; A Rao
Journal:  J Clin Immunol       Date:  1999-03       Impact factor: 8.317

Review 2.  How diverse--CD4 effector T cells and their functions.

Authors:  Yisong Y Wan; Richard A Flavell
Journal:  J Mol Cell Biol       Date:  2009-05-28       Impact factor: 6.216

3.  Expression of interferon consensus sequence binding protein (ICSBP) is downregulated in Bcr-Abl-induced murine chronic myelogenous leukemia-like disease, and forced coexpression of ICSBP inhibits Bcr-Abl-induced myeloproliferative disorder.

Authors:  S X Hao; R Ren
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

4.  In situ regulation of DC subsets and T cells mediates tumor regression in mice.

Authors:  Omar A Ali; Dwaine Emerich; Glenn Dranoff; David J Mooney
Journal:  Sci Transl Med       Date:  2009-11-25       Impact factor: 17.956

5.  Inherited defects in the interferon-gamma receptor or interleukin-12 signalling pathways are not sufficient to cause allergic disease in children.

Authors:  Philip M D Wood; Claire Fieschi; Capucine Picard; Tom H M Ottenhoff; Jean-Laurent Casanova; Dinakantha S Kumararatne
Journal:  Eur J Pediatr       Date:  2005-08-23       Impact factor: 3.183

Review 6.  Pristane-induced lupus: considerations on this experimental model.

Authors:  Eduarda Correa Freitas; Mayara Souza de Oliveira; Odirlei André Monticielo
Journal:  Clin Rheumatol       Date:  2017-09-06       Impact factor: 2.980

7.  Role of interleukin-4 (IL-4), IL-12, and gamma interferon in primary and vaccine-primed immune responses to Friend retrovirus infection.

Authors:  U Dittmer; K E Peterson; R Messer; I M Stromnes; B Race; K J Hasenkrug
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

8.  Role of endogenous interleukin-18 in resolving wild-type and attenuated Salmonella typhimurium infections.

Authors:  J K Dybing; N Walters; D W Pascual
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

Review 9.  The power of combinatorial immunology: IL-12 and IL-12-related dimeric cytokines in infectious diseases.

Authors:  Christoph Hölscher
Journal:  Med Microbiol Immunol       Date:  2003-06-27       Impact factor: 3.402

10.  BOB.1/OBF.1 controls the balance of TH1 and TH2 immune responses.

Authors:  Cornelia Brunner; Anca Sindrilaru; Irute Girkontaite; Klaus-Dieter Fischer; Cord Sunderkötter; Thomas Wirth
Journal:  EMBO J       Date:  2007-06-14       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.